Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

• Status: COMPLETED
• Trial end date: 2025-02-08

Summary

Single dose oral bioequivalence study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo (Bempedoic Acid) 180 mg Film-coated tablets in healthy adult human subjects under fasting conditions.

• Phase: PHASE1

Details

• Lead Sponsor: Humanis Saglk Anonim Sirketi
• Treatments: 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid